The ghrelin receptor, and what else it does
GHRP-6 is a six-residue synthetic peptide acting at the ghrelin receptor, one of the first compounds to establish that this receptor could be used to drive growth hormone release at all.
Ghrelin is also the hormone that signals hunger. Agonism at its receptor does both jobs, and with GHRP-6 the appetite effect is pronounced enough to be its defining characteristic in practice.
There are two separate doorways into growth hormone release, and this compound uses the second one. The releasing-hormone route works through a receptor of its own and is set out on the sermorelin page; the ghrelin receptor is a different signal arriving at the same pituitary cells, which is why compounds from the two families are studied together about as often as separately. What the released hormone then does is largely a story about IGF-1, which is why the IGF-1 LR3 page sits next to this one.
Why selectivity became the goal
Along with appetite, GHRP-6 raises cortisol and prolactin. Between them, these three effects meant the compound moved several hormonal systems when the intention was to move one.
Ipamorelin came out of the effort to fix that. It reaches the same receptor and was designed to produce the growth hormone response without the appetite, cortisol and prolactin effects that characterise the earlier compounds.
The appetite effect is a methodological obstacle as well as a practical one. In an animal study where intake is not controlled, a compound that drives feeding will move body composition by that route as well as by any hormonal one, and telling the two apart takes deliberate design rather than careful wording afterwards.
| Length | 6 amino acids |
| Target | Ghrelin receptor |
| Best known for | Pronounced appetite stimulation |
| Other effects | Cortisol and prolactin rise |
| Superseded by | Ipamorelin |
| Stocked here | No, reference page |
| Closest product | Ipamorelin peptide pen |
| Category | Research use only |
What analysis established about this batch type. No claim follows from it.
We do not supply GHRP-6
The selective successor is in the catalogue. Carrying the older compound alongside it would only make sense if we explained the difference at the point of sale, and by then you would choose the newer one anyway.
The one situation where GHRP-6 remains genuinely interesting is research where the appetite effect is the thing being studied rather than a nuisance. That is a narrow use, and not one we supply for.
Anyone asking what is GHRP-6 in a metabolic context should notice that the answer points the opposite way to almost every other compound in that conversation. The weight and metabolism area gathers the ones that reduce intake rather than drive it, which is a different research question wearing similar vocabulary.
What the literature settles and what it leaves
The published work on this compound sits mostly in the physiology that established the class: receptor characterisation, hormone release measurements, and the feeding observations that followed from them. The indexed literature on PubMed reflects that emphasis, and the publication dates cluster accordingly.
Identity is at least easy to pin down for a molecule this small. The structure record on PubChem carries the formula and the accumulated synonyms, which is more useful than it sounds: this peptide travels under several abbreviations and codes across supplier listings, and they are not always the same molecule.
What none of that settles is what the compound would do outside a laboratory, and no page here will try. Everything discussed on this site falls under the research use only classification, which describes what the material is for rather than serving as a formality at the bottom of the screen.
GHRP-6 in the catalogue
Verified at 99% or higher before release, certificate available per batch.
Where GHRP-6 fits in
Further reading, chosen for relevance rather than volume.
About GHRP-6
What comes up before most orders.